- Home
- UEIC vs ALGS Comparison
UEIC vs ALGS Comparison
Compare UEIC & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UEIC
- ALGS
- Stock Information
- Founded
- UEIC 1986
- ALGS 2018
- Country
- UEIC United States
- ALGS United States
- Employees
- UEIC N/A
- ALGS N/A
- Industry
- UEIC Consumer Electronics/Appliances
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- UEIC Consumer Staples
- ALGS Health Care
- Exchange
- UEIC Nasdaq
- ALGS Nasdaq
- Market Cap
- UEIC 88.0M
- ALGS 72.6M
- IPO Year
- UEIC 1993
- ALGS 2020
- Fundamental
- Price
- UEIC $4.36
- ALGS $9.72
- Analyst Decision
- UEIC Buy
- ALGS Strong Buy
- Analyst Count
- UEIC 2
- ALGS 2
- Target Price
- UEIC $10.00
- ALGS $60.00
- AVG Volume (30 Days)
- UEIC 67.4K
- ALGS 94.0K
- Earning Date
- UEIC 11-06-2025
- ALGS 11-10-2025
- Dividend Yield
- UEIC N/A
- ALGS N/A
- EPS Growth
- UEIC N/A
- ALGS N/A
- EPS
- UEIC N/A
- ALGS N/A
- Revenue
- UEIC $402,518,000.00
- ALGS $3,174,000.00
- Revenue This Year
- UEIC $0.57
- ALGS N/A
- Revenue Next Year
- UEIC N/A
- ALGS N/A
- P/E Ratio
- UEIC N/A
- ALGS N/A
- Revenue Growth
- UEIC 4.00
- ALGS N/A
- 52 Week Low
- UEIC $4.24
- ALGS $3.76
- 52 Week High
- UEIC $12.50
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- UEIC 41.70
- ALGS 47.63
- Support Level
- UEIC $4.34
- ALGS $9.25
- Resistance Level
- UEIC $4.55
- ALGS $10.89
- Average True Range (ATR)
- UEIC 0.19
- ALGS 0.80
- MACD
- UEIC -0.01
- ALGS -0.04
- Stochastic Oscillator
- UEIC 22.64
- ALGS 32.11
About UEIC Universal Electronics Inc.
Universal Electronics Inc is a United States-based company that principally designs, develops, manufactures, ships, and supports control and sensor technology solutions and a broad line of universal control systems, audio-video (AV) accessories, wireless security, and smart home products that are used by the world's brands in the video services, consumer electronics, security, home automation, climate control and home appliance markets. It generates its total revenue from the United States.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.